BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32322956)

  • 1. Single-nucleotide variants in human CD81 influence hepatitis C virus infection of hepatoma cells.
    Alberione MP; Moeller R; Kirui J; Ginkel C; Doepke M; Ströh LJ; Machtens JP; Pietschmann T; Gerold G
    Med Microbiol Immunol; 2020 Aug; 209(4):499-514. PubMed ID: 32322956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
    Banse P; Moeller R; Bruening J; Lasswitz L; Kahl S; Khan AG; Marcotrigiano J; Pietschmann T; Gerold G
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29677132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of ligand interactions of the large extracellular domain of tetraspanin CD81.
    Rajesh S; Sridhar P; Tews BA; Fénéant L; Cocquerel L; Ward DG; Berditchevski F; Overduin M
    J Virol; 2012 Sep; 86(18):9606-16. PubMed ID: 22740401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mice Expressing Minimally Humanized CD81 and Occludin Genes Support Hepatitis C Virus Uptake In Vivo.
    Ding Q; von Schaewen M; Hrebikova G; Heller B; Sandmann L; Plaas M; Ploss A
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An intramolecular bond at cluster of differentiation 81 ectodomain is important for hepatitis C virus entry.
    Yang W; Zhang M; Chi X; Liu X; Qin B; Cui S
    FASEB J; 2015 Oct; 29(10):4214-26. PubMed ID: 26116703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Conserved E2 Residue W420 in Receptor Binding and Hepatitis C Virus Infection.
    Cowton VM; Angus AGN; Cole SJ; Markopoulou CK; Owsianka A; Dunlop JI; Gardner DE; Krey T; Patel AH
    J Virol; 2016 Aug; 90(16):7456-7468. PubMed ID: 27279607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two conserved histidines (His490 and His621) on the E2 glycoprotein of hepatitis C virus are critical for CD81-mediated cell entry.
    Qin ZL; Ju HP; Gao TT; Wang WB; Ren H; Zhao P; Qi ZT
    J Gen Virol; 2015 Jun; 96(Pt 6):1389-1399. PubMed ID: 25701820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimized cell systems for the investigation of hepatitis C virus E1E2 glycoproteins.
    Kalemera MD; Capella-Pujol J; Chumbe A; Underwood A; Bull RA; Schinkel J; Sliepen K; Grove J
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33147126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverse CD81 proteins support hepatitis C virus infection.
    Flint M; von Hahn T; Zhang J; Farquhar M; Jones CT; Balfe P; Rice CM; McKeating JA
    J Virol; 2006 Nov; 80(22):11331-42. PubMed ID: 16943299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-derived hepatitis C virus infection of primary human hepatocytes is tetraspanin CD81 dependent.
    Molina S; Castet V; Pichard-Garcia L; Wychowski C; Meurs E; Pascussi JM; Sureau C; Fabre JM; Sacunha A; Larrey D; Dubuisson J; Coste J; McKeating J; Maurel P; Fournier-Wirth C
    J Virol; 2008 Jan; 82(1):569-74. PubMed ID: 17942559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD81 large extracellular loop-containing fusion proteins with a dominant negative effect on HCV cell spread and replication.
    Grigorov B; Molle J; Rubinstein E; Zoulim F; Bartosch B
    J Gen Virol; 2017 Jul; 98(7):1646-1657. PubMed ID: 28721844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry.
    Rocha-Perugini V; Lavie M; Delgrange D; Canton J; Pillez A; Potel J; Lecoeur C; Rubinstein E; Dubuisson J; Wychowski C; Cocquerel L
    BMC Microbiol; 2009 May; 9():111. PubMed ID: 19476617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry.
    Padmanabhan P; Dixit NM
    PLoS Comput Biol; 2011 Dec; 7(12):e1002307. PubMed ID: 22174670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of conserved residues in hepatitis C virus envelope glycoprotein E2 that modulate virus dependence on CD81 and SRB1 entry factors.
    Lavie M; Sarrazin S; Montserret R; Descamps V; Baumert TF; Duverlie G; Séron K; Penin F; Dubuisson J
    J Virol; 2014 Sep; 88(18):10584-97. PubMed ID: 24990994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Structural Tuning of the Hepatitis C Virus Human Cellular Receptor CD81 Large Extracellular Loop.
    Cunha ES; Sfriso P; Rojas AL; Roversi P; Hospital A; Orozco M; Abrescia NGA
    Structure; 2017 Jan; 25(1):53-65. PubMed ID: 27916518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.
    Zhang J; Randall G; Higginbottom A; Monk P; Rice CM; McKeating JA
    J Virol; 2004 Feb; 78(3):1448-55. PubMed ID: 14722300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding the Host Range of Hepatitis C Virus through Viral Adaptation.
    von Schaewen M; Dorner M; Hueging K; Foquet L; Gerges S; Hrebikova G; Heller B; Bitzegeio J; Doerrbecker J; Horwitz JA; Gerold G; Suerbaum S; Rice CM; Meuleman P; Pietschmann T; Ploss A
    mBio; 2016 Nov; 7(6):. PubMed ID: 27834208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.
    Kachko A; Costafreda MI; Zubkova I; Jacques J; Takeda K; Wells F; Kaplan G; Major ME
    J Virol; 2018 Mar; 92(6):. PubMed ID: 29321304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural insights into hepatitis C virus receptor binding and entry.
    Kumar A; Hossain RA; Yost SA; Bu W; Wang Y; Dearborn AD; Grakoui A; Cohen JI; Marcotrigiano J
    Nature; 2021 Oct; 598(7881):521-525. PubMed ID: 34526719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLEC4M-positive and CD81-negative Huh7 cells are not susceptible to JFH-1 HCVcc infection but mediate transinfection.
    Ishibashi M; Morita N; Nomura-Kawaguchi C; Shimizu Y; Wakita T; Esumi M
    Arch Virol; 2014 Nov; 159(11):2949-55. PubMed ID: 24965233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.